Literature DB >> 24487881

Megahertz all-optical swept-source optical coherence tomography based on broadband amplified optical time-stretch.

Jingjiang Xu, Chi Zhang, Jianbing Xu, K K Y Wong, K K Tsia.   

Abstract

We demonstrate all-optical ultrahigh-speed swept-source optical coherence tomography (OCT) based on amplified optical time-stretch (AOT). Such an inertia-free wavelength-swept mechanism, via group velocity dispersion, enables us to realize OCT with an A-scan rate well above MHz. More importantly, the key significance of AOT-OCT is its simultaneous broadband Raman amplification during the time-stretch process-greatly enhancing the detection sensitivity compared with prior attempts to apply optical time-stretch to OCT. Here, we report on an AOT-OCT system which is operated at an A-scan rate of 7.14 MHz, a superior roll-off performance (>2 mm/dB), a record-high sensitivity of time-stretch-based OCT (>80 dB) with a broadband gain bandwidth of 80 nm, which results in an axial resolution of ∼15 μm. Our AOT-OCT system is thus able to, for the first time to the best of our knowledge, perform time-stretch-based OCT of biological tissue in vivo. It represents a major step forward in utilizing AOT as an alternative for achieving practical MHz OCT, without any long-term mechanical stability concerns as in typical swept-source OCT or bypassing the speed limitation of the image sensor employed in spectral-domain OCT.

Mesh:

Year:  2014        PMID: 24487881     DOI: 10.1364/OL.39.000622

Source DB:  PubMed          Journal:  Opt Lett        ISSN: 0146-9592            Impact factor:   3.776


  16 in total

1.  28 MHz swept source at 1.0 μm for ultrafast quantitative phase imaging.

Authors:  Xiaoming Wei; Andy K S Lau; Yiqing Xu; Kevin K Tsia; Kenneth K Y Wong
Journal:  Biomed Opt Express       Date:  2015-09-08       Impact factor: 3.732

2.  High-performance multi-megahertz optical coherence tomography based on amplified optical time-stretch.

Authors:  Jingjiang Xu; Xiaoming Wei; Luoqin Yu; Chi Zhang; Jianbing Xu; K K Y Wong; Kevin K Tsia
Journal:  Biomed Opt Express       Date:  2015-03-18       Impact factor: 3.732

3.  Multi-beam OCT imaging based on an integrated, free-space interferometer.

Authors:  Yongjoo Kim; Norman Lippok; Benjamin J Vakoc
Journal:  Biomed Opt Express       Date:  2020-12-08       Impact factor: 3.732

4.  Wide field and highly sensitive angiography based on optical coherence tomography with akinetic swept source.

Authors:  Jingjiang Xu; Shaozhen Song; Wei Wei; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2016-12-22       Impact factor: 3.732

Review 5.  High-speed OCT light sources and systems [Invited].

Authors:  Thomas Klein; Robert Huber
Journal:  Biomed Opt Express       Date:  2017-01-13       Impact factor: 3.732

6.  Long-range and wide field of view optical coherence tomography for in vivo 3D imaging of large volume object based on akinetic programmable swept source.

Authors:  Shaozhen Song; Jingjiang Xu; Ruikang K Wang
Journal:  Biomed Opt Express       Date:  2016-10-27       Impact factor: 3.732

7.  Phase-stability optimization of swept-source optical coherence tomography.

Authors:  Sucbei Moon; Zhongping Chen
Journal:  Biomed Opt Express       Date:  2018-10-09       Impact factor: 3.732

8.  Evaluating changes of blood flow in retina, choroid, and outer choroid in rats in response to elevated intraocular pressure by 1300 nm swept-source OCT.

Authors:  Jingjiang Xu; Yuandong Li; Shaozhen Song; William Cepurna; John Morrison; Ruikang K Wang
Journal:  Microvasc Res       Date:  2018-09-26       Impact factor: 3.514

9.  Molecular Imaging in Optical Coherence Tomography.

Authors:  Scott P Mattison; Wihan Kim; Jesung Park; Brian E Applegate
Journal:  Curr Mol Imaging       Date:  2014-07-01

10.  Long ranging swept-source optical coherence tomography-based angiography outperforms its spectral-domain counterpart in imaging human skin microcirculations.

Authors:  Jingjiang Xu; Shaozhen Song; Shaojie Men; Ruikang K Wang
Journal:  J Biomed Opt       Date:  2017-11       Impact factor: 3.170

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.